Ensign traded at $172.75 this Tuesday September 15th, decreasing $2.18 or 1.25 percent since the previous trading session. Looking back, over the last four weeks, Ensign lost 4.84 percent. Over the last 12 months, its price rose by 5.12 percent. Looking ahead, we forecast Ensign to be priced at 170.26 by the end of this quarter and at 159.56 in one year, according to Trading Economics global macro models projections and analysts expectations.
Ensign Group, Inc., through its operating subsidiaries, provides healthcare services. The Company's operating subsidiaries provide a spectrum of skilled nursing services, physical, occupational and speech therapies and other rehabilitative and healthcare services. The Company operates approximately 236 healthcare facilities, 24 of which also include assisted living operations across thirteen states. It operates the healthcare facilities across Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. Through its skilled nursing operations, the Company provides short stay patients and long stay patients with a range of medical, nursing, rehabilitative, pharmacy and routine services, including daily dietary, social and recreational services.